News

Columnist Caroline Gainer weighs in on how changes with her doctors have affected her ability to coordinate care for her COPD ...
Yupelri (revefenacin) is an approved once-daily maintenance therapy developed by Theravance Biopharma and Mylan (now part of Viatris) for chronic obstructive pulmonary disease (COPD). Its U.S.
Digital inhalers that allow remote patient monitoring may predict impending exacerbations, or episodes when symptoms of COPD suddenly worsen.
Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder that causes several symptoms which make breathing difficult. These include persistent cough with mucus, wheezing, and shortness ...
While the risk of COPD was highest among traditional cigarette smokers and dual users, e-cigarette users also had a significantly increased risk of COPD over people who’d never used e-cigarettes or ...
The Verona Pharma therapy, with a list price of $2,950 for a monthly supply, was cleared by the U.S. Food and Drug Administration in June as an inhaled maintenance therapy for adults with COPD. “We ...
The reason I’m telling you about cachexia is personal. My normal weight for 30 years was 113 pounds. The nurse in my doctor’s office once said that if the scales didn’t show 113 when I got on them, ...
“Knowing the potential benefits of tai chi, we hypothesized that, in patients being treated with medication to manage their COPD symptoms, it could help improve the quality of life when compared to a ...
Dr. Noah Greenspan is a board-certified clinical specialist in cardiovascular and pulmonary physical therapy, with more than 25 years of cardiopulmonary physical therapy and rehabilitation experience.
Secondary goals include assessing changes in symptom severity and patients’ health-related quality of life, evaluated over the trials’ course. Safety assessments will also be conducted over the 24 ...
It is sold as Spiriva HandiHaler, a dry powder inhaler approved in 2004, or as Spiriva Respimat, an inhalation spray approved in 2014. The Phase 4 trial — a type of study conducted after a medication ...